prostate

Timothy Yap MD PhD MBBS selective PARP inhibitor promise in breast, ovarian, pancreatic, prostate tumors.

Cora Sternberg REFERENCE: Abstract 4010, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 CORA STERNBERG, San Camillo and Forlanini Hospital, Rome Satraplatin could pro

Fritz Schröder Opportunistic Prostate Screening May Not Save Lives! REFERENCE: AACR 2007, Los Angeles FRITZ SCHRÖDER, Erasmus University, Rotterdam Though elective screening appears to have reduced

Daniel Petrylak Oliver Sartor Mark Socinski Kanti Rai Edward Ambinder Chemo- and Immunotherapy Working Together in Hormone Refractory Prostate Cancer REFERENCE: Chemotherapy Foundation Symposium XXIV

Robert Ozols William See Ruth Lupu Improving on Standard Treatment in Ovarian Cancer: Have We Hit a Wall? REFERENCE: Abstract 5002, 2006 ASCO Annual Meeting; N Engl J Med 2006, 354:34-43 ROBERT OZOLS,

David Cunningham Kenneth MacDonald Mark Pomerantz Jorge Garcia REFERENCE: N Engl J Med 2006;355:11 David Cunningham, Royal Marsden Hospital The July 6th edition of the New England Journal of Me

Reporting from: – 2005 Multidisciplinary Prostate Cancer Symposium, February 17-19, Hyatt Grand Cypress, Orlando, Florida In this edition: Will they or won’t they relapse? For patients wit